Restlessness aggravated and Hyperkalemia

Summary:

Hyperkalemia is found among people with Restlessness aggravated, especially for people who are male, 60+ old.

The study analyzes which people have Hyperkalemia with Restlessness aggravated. It is created by eHealthMe based on reports of 76 people who have Restlessness aggravated from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Restlessness aggravated?

Restlessness aggravated (not able to rest) is found to be associated with 1,528 drugs and 564 conditions by eHealthMe. Check the latest studies of Restlessness aggravated.

What is Hyperkalemia?

Hyperkalemia (damage to or disease of the kidney) is found to be associated with 1,951 drugs and 2,941 conditions by eHealthMe. Check the latest studies of Hyperkalemia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

76 people who have Restlessness Aggravated and Hyperkalemia are studied.

Would you have Hyperkalemia when you have Restlessness aggravated?

Gender of people who have Restlessness Aggravated and experienced Hyperkalemia *:

female: 30.56 %
male: 69.44 %

Age of people who have Restlessness Aggravated and experienced Hyperkalemia *:

Common co-existing conditions for these people *:

High Blood Pressure: 19 people, 25.00%
Mechanical Ventilation Complication: 12 people, 15.79%
Stress And Anxiety: 12 people, 15.79%
Pain: 11 people, 14.47%
Cardiac Failure: 8 people, 10.53%
Nausea (feeling of having an urge to vomit): 7 people, 9.21%
Constipation: 7 people, 9.21%
Insomnia (sleeplessness): 6 people, 7.89%
Dementia (madness): 6 people, 7.89%
Sedation: 6 people, 7.89%

Common drugs taken by these people *:

Common symptoms for these people *:

Neuroleptic Malignant Syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents): 20 people, 26.32%
Hypotension (abnormally low blood pressure): 20 people, 26.32%
Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down): 13 people, 17.11%
Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 13 people, 17.11%
Pulseless Electrical Activity: 9 people, 11.84%
Blood Creatinine Increased: 9 people, 11.84%
Haemoglobin Decreased: 9 people, 11.84%
Dyspnea (difficult or laboured breathing): 9 people, 11.84%
Dehydration (dryness resulting from the removal of water): 9 people, 11.84%
Ventricular Arrhythmia (problem with the rate or rhythm of the heartbeat): 9 people, 11.84%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Hyperkalemia?

- Check whether Hyperkalemia is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Restlessness aggravated (51 reports)
Hyperkalemia (78,085 reports)

All the drugs that are associated with Hyperkalemia:

Hyperkalemia (1,951 drugs)

All the conditions that are associated with Hyperkalemia:

Hyperkalemia (2,941 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Hyperkalemia and Restlessness aggravated, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.